Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins

Multiple myeloma arises when malignant plasma cells invade and form multiple tumors in the bone marrow. High levels of heparanase (HPSE) correlate with poor prognosis in myeloma patients. A likely target of the enzyme is the heparan sulfate (HS) proteoglycan syndecan-1 (Sdc1, CD138), which is highly...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncogenesis
Autori principali: Jung, O, Trapp-Stamborski, V, Purushothaman, A, Jin, H, Wang, H, Sanderson, R D, Rapraeger, A C
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154350/
https://ncbi.nlm.nih.gov/pubmed/26926788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oncsis.2016.5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi